This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Teikoku Pharma USA, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Susan Meier-Davis: Innovator in Skin Neoplasm Treatment
Introduction
Susan Meier-Davis is a notable inventor based in San Jose, California. She has made significant contributions to the field of dermatology, particularly in the treatment of skin neoplasms. Her innovative approach has led to the development of effective methods that utilize monoamine oxidase inhibitors.
Latest Patents
Susan holds 1 patent for her work titled "Methods for the treatment of skin neoplasms." This patent outlines methods of treating skin neoplasms using a monoamine oxidase inhibitor, such as rasagiline. Additionally, her patent includes pharmaceutical compositions and kits that comprise these inhibitors, showcasing her commitment to advancing medical treatments.
Career Highlights
Throughout her career, Susan has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Teikoku Pharma USA, Inc. and Teikoku Seiyaku Co., Ltd. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research.
Collaborations
Susan has collaborated with esteemed colleagues, including Jianye Wen and Richard D. Hamlin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Susan Meier-Davis is a pioneering inventor whose work in the treatment of skin neoplasms has the potential to impact many lives. Her dedication to research and collaboration exemplifies the spirit of innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile